Description
Disease Indications
Primary Biliary Cholangitis (PBC)
Manufacturer
Novartis
Usage
Oral
Medicine approved by
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Price range: $1,000.00 through $5,000.00
Isturisa (osilodrostat) is a medication used for the treatment of adult patients with Cushing’s syndrome or for adults with Cushing’s disease who are not candidates for surgery, or who did not respond to prior surgery.
Disease Indications
Primary Biliary Cholangitis (PBC)
Manufacturer
Novartis
Usage
Oral
Medicine approved by
European Medical Agency (EMA)
Food and Drug Administration (FDA)
| Package Tablets | 60 tablets of 1 mg, 60 tablets of 5 mg, 60 tablets of 10 mg |
|---|
Reviews
There are no reviews yet.